INSP Inspire Medical Systems, Inc.

$67.54 -0.73%

Data as of Nov 2, 2026 close

Healthcare · Surgical & Medical Instruments & Apparatus

Inspire Medical Systems, Inc. (INSP) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $2.0 billion. Shares last traded at $67.54, 53.9% below their 52-week high. Over the past year the stock is down 7.5%. INSP trades at a price-to-earnings ratio of 19.42, below the Surgical & Medical Instruments & Apparatus median of 28.34. Net profit margin is 11.4%, above the peer median of -6.9%. Revenue grew 13.6% year over year.

Market Cap

$2.0B

Shares Out

29.0M

EPS (TTM)

$3.35

P/E (TTM)*

19.42

P/S Ratio

2.22

P/B Ratio

2.37

Dividend / Share

—

Dividend Yield

—

52-Week High

$146.56

52-Week Low

$38.87

Volume (venue)

88,582

Avg Vol (3m, venue)

37,424.111

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

-4.86%

-3.50%

+5.24%

+47.18%

YTD

-26.71%

-7.52%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

44.05

SMA (50)

$68.71

SMA (200)

$58.40

Price vs SMA50

-1.71%

Price vs SMA200

+15.64%

ATR (14)

$3.01

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$881M

Net Income

$101M

Gross Margin

86.2%

Operating Margin

1.8%

Net Margin

11.4%

Return on Equity

12.2%

Return on Assets

10.6%

Current Ratio

6.45

Debt / Equity

0.03

Revenue Growth (YoY)

+13.6%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-09-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q3 2026	-$0.84	2026-11-02
Q2 2026	$0.01	2026-08-03
Q1 2026	-$0.39	2026-05-04
Q4 2025 (derived)	$4.57	2026-02-13
FY 2025	$4.89	2026-02-13
Q3 2025	$0.34	2025-11-03

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

INSP vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Data as of Nov 2, 2026 close

P/E vs peers

19.42 / 28.34 med

-31% discount

P/S vs peers

2.22 / 2.81 med

-21% discount

Net margin vs peers

11.4% / -6.9% med

above median

1–14 of 14


SYK	Stryker Corporation	$116.8B	32.25	4.44	13.8%	+5.32%
MMM	3M	$92.2B	26.07	3.65	14.0%	+2.35%
BSX	Boston Scientific	$64.3B	18.39	3.05	16.6%	+5.62%
BDX	Becton Dickinson	$54.1B	57.49	2.60	4.5%	+0.39%
RMD	ResMed	$32.8B	20.56	5.71	27.8%	+1.35%
DXCM	DexCom	$31.6B	31.90	6.19	19.4%	+2.99%
MDLN	Medline Inc.	$29.5B	—	1.04	—	+4.80%
WST	West Pharmaceutical Services	$28.4B	44.46	8.36	18.8%	-1.15%
SOLV	Solventum	$14.4B	10.06	1.74	17.3%	+4.22%
GKOS	Glaukos Corp	$14.1B	—	20.48	-24.6%	+0.53%
PEN	Penumbra Inc	$12.7B	80.67	9.02	11.2%	+0.42%
BAX	Baxter International	$12.5B	—	1.08	-6.2%	+5.47%
GMED	Globus Medical Inc	$10.7B	19.92	3.39	17.0%	+1.81%
PODD	Insulet Corporation	$10.7B	28.39	3.49	12.3%	+2.58%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.